Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer

NCT05193292 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms
Intestinal Neoplasms

Interventions

DRUG: Camrelizumab
DRUG: Trastuzumab
DRUG: XELOX regimen
DRUG: mFOLFOX6 regimen
DRUG: FOLFIRI regimen
DRUG: mXELIRI regimen
DRUG: mIRIS regimen

Sponsor

Fudan University